Special report on the impact of the COVID-19 pandemic on clinical EEG and research and consensus recommendations for the safe use of EEG

Salvatore Campanella, Kemal Arikan, Claudio Babiloni, Michela Balconi, Maurizio Bertollo, Viviana Betti, Luigi Bianchi, Martin Brunovsky, Carla Buttinelli, Silvia Comani, Giorgio Di Lorenzo, Daniel Dumalin, Carles Escera, Andreas Fallgatter, Derek Fisher, Giulia Maria Giordano, Bahar Guntekin, Claudio Imperatori, Ryouhei Ishii, Hendrik KajoschMichael Kiang, Eduardo López-Caneda, Pascal Missonnier, Armida Mucci, Sebastian Olbrich, Georges Otte, Andrea Perrottelli, Alessandra Pizzuti, Diego Pinal, Dean Salisbury, Yingying Tang, Paolo Tisei, Jijun Wang, Istvan Winkler, Jiajin Yuan, Oliver Pogarell

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review


Introduction: The global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic. Methods: Fifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities. Results: Of the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants. Conclusions: The COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.
Lingua originaleEnglish
pagine (da-a)3-28
Numero di pagine26
RivistaClinical EEG and Neuroscience
Stato di pubblicazionePubblicato - 2021


  • Brain
  • Brain Mapping
  • COVID-19
  • Consensus
  • Electroencephalography
  • Humans
  • Mental Disorders
  • SARS-CoV-2
  • event-related oscillations (EROs)
  • event-related potentials (ERPs)
  • psychiatry
  • quantitative EEG (qEEG)
  • resting state electroencephalography (rsEEG)


Entra nei temi di ricerca di 'Special report on the impact of the COVID-19 pandemic on clinical EEG and research and consensus recommendations for the safe use of EEG'. Insieme formano una fingerprint unica.

Cita questo